Public Interest in Montelukast Prior to and After Announcement of Black Box Warning and Associations With Adverse Event Reports.

Q2 Medicine

Journal of Pediatric Pharmacology and Therapeutics Pub Date : 2024-01-01 Epub Date: 2024-02-07 DOI:10.5863/1551-6776-29.1.90

Samer Abdelkader, Micah Hartwell, Amy D Hendrix-Dicken, Michelle Escala, Michelle Condren

引用次数: 0

查看原文本刊更多论文

公布黑框警告前后公众对孟鲁司特的兴趣以及与不良事件报告的关联。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Pediatric Pharmacology and Therapeutics Medicine-Pediatrics, Perinatology and Child Health

CiteScore

2.40

自引率

0.00%

发文量

期刊介绍： The Journal of Pediatric Pharmacology and Therapeutics is the official journal of the Pediatric Pharmacy Advocacy Group. JPPT is a peer-reviewed multi disciplinary journal that is devoted to promoting the safe and effective use of medications in infants and children. To this end, the journal publishes practical information for all practitioners who provide care to pediatric patients. Each issue includes review articles, original clinical investigations, case reports, editorials, and other information relevant to pediatric medication therapy. The Journal focuses all work on issues related to the practice of pediatric pharmacology and therapeutics. The scope of content includes pharmacotherapy, extemporaneous compounding, dosing, methods of medication administration, medication error prevention, and legislative issues. The Journal will contain original research, review articles, short subjects, case reports, clinical investigations, editorials, and news from such organizations as the Pediatric Pharmacy Advocacy Group, the FDA, the American Academy of Pediatrics, the American Society of Health-System Pharmacists, and so on.